Physician profile
Frederick Berg
NPI 1972815348
$4,223.85
in general payments reported to CMS, 2019-2025
28 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,762 · 2020: $338 · 2021: $386 · 2022: $569 · 2023: $873 · 2024: $124 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141 · Education: $28.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.94 |
| Education | $28.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,449.24 | 2019-2023 | Titan, Speedicath |
| Astellas Pharma US INC | $544.25 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $280.76 | 2019-2024 | Lithovue, Rezum Generator |
| Axonics, INC. | $238.38 | 2022-2023 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $237.18 | 2021-2025 | |
| Pfizer INC. | $159.39 | 2019-2023 | |
| Janssen Biotech, INC. | $148.65 | 2019-2025 | Erleada, Akeega |
| Neotract INC. | $140.69 | 2019 | |
| Abbvie INC. | $130.46 | 2019-2023 | Lupron Depot |
| Myriad Genetic Laboratories, INC. | $129.06 | 2023 | Prolaris |
| Medtronic, INC. | $91.62 | 2022 | |
| Sumitomo Pharma America, INC. | $89.39 | 2023 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $86.24 | 2021-2022 | |
| Teleflex LLC | $72.66 | 2022-2023 | Urolift |
| Allergan, INC. | $71.57 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $59.28 | 2021-2023 | |
| Myovant Sciences INC. | $51.29 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $33.84 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $31.63 | 2019 | |
| Merck Sharp & Dohme LLC | $28.42 | 2023 | Keytruda |
| Astrazeneca Pharmaceuticals Lp | $27.43 | 2020-2021 | |
| Curium US LLC | $24.71 | 2023 | |
| Baxter Healthcare | $23.08 | 2023 | Tisseel |
| Endo USA, INC. | $17.81 | 2024 | Xiaflex |
| Convatec INC. | $16.11 | 2021 | |
| Procept Biorobotics Corporation | $15.82 | 2019 | |
| Olympus America INC. | $13.52 | 2020 | |
| Therapeuticsmd, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.